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Background: The doctor-patient encounter (DPE) and associated patient expectations are potential confounders in
open-label randomized trials of treatment efficacy. It is therefore important to evaluate the effects of the DPE on
study outcomes.
Methods: Four hundred participants with chronic low back pain (LBP) were randomized to four dose groups: 0, 6,
12, or 18 sessions of spinal manipulation from a chiropractor. Participants were treated three times per week for six
weeks. They received light massage control at visits when manipulation was not scheduled. Treating chiropractors
were instructed to have equal enthusiasm for both interventions. A path analysis was conducted to determine the
effects of dose, patient expectations of treatment success, and DPE on LBP intensity (100-point scale) at the end of
care (6 weeks) and primary endpoint (12 weeks). Direct, indirect, and total standardized effects (βtotal) were
computed. Expectations and DPE were evaluated on Likert scales. The DPE was assessed as patient-rated perception
of chiropractor enthusiasm, confidence, comfort with care, and time spent.
Results: The DPE was successfully balanced across groups, as were baseline expectations. The principal finding was
that the magnitude of the effects of DPE on LBP at 6 and 12 weeks (|β|total = 0.22 and 0.15, p < .05) were
comparable to the effects of dose of manipulation at those times (|β|total = 0.11 and 0.12, p < .05). In addition,
baseline expectations had no notable effect on follow-up LBP. Subsequent expectations were affected by LBP, DPE,
and dose (p < .05).
Conclusions: The DPE can have a relatively important effect on outcomes in open-label randomized trials of
treatment efficacy. Therefore, attempts should be made to balance the DPE across treatment groups and report
degree of success in study publications. We balanced the DPE across groups with minimal training of treatment
providers.
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The therapeutic effects of care are complex and not lim-
ited to the consequences of a specific intervention [1].
Hence, nonspecific effects of care clearly need to be ad-
dressed in the design of randomized trials. Patient re-
sponse expectancy can be an important contributor to
the treatment effect [2,3]. Provider enthusiasm during
the treatment visit can also have a positive effect on out-
comes [4].
Four trials and a nonrandomized comparison study of
care for low back pain (LBP) have reported the effects of
baseline expectation of treatment success on functional
disability with mixed results. For acute LBP, general ex-
pectancy of success, but not expectation of specific treat-
ments’ success, was observed to be a determinant in a
choice trial that included chiropractic as an option [5].
The nonrandomized study found important and compar-
able effects of expectation for both manual and mechan-
ical spinal manipulation techniques by chiropractors [6].
For chronic LBP, expectation of success in the treatment
that the participant received was an important determin-
ant of outcomes in a comparison of acupuncture and
massage [7]. Expectancy also affected outcomes in a trial
comparing physical therapy, cognitive-behavioral therapy
and combination of the two [8]. In contrast, expectation
of success did not affect outcomes in a more recent trial
comparing acupuncture, sham acupuncture, and medical
care [9]. For pain outcomes, the nonrandomized study
on acute LBP found no effect of expectation, in juxta-
position to the effect on functional disability [6]. None
of these studies looked at the influence of evolving ex-
pectations over time, as well as the effect of doctor-
patient encounter (DPE) on outcomes.
Blinding of participant and provider are important for
establishing the internal validity for randomized trials of
treatment efficacy [10] and are universally included as
important components of quality scoring instruments
used for systematic reviews of randomized trials [11,12].
Blinding serves to control the effects of expectancy of
treatment success and the nonspecific effects of DPE
across groups in studies of efficacy, where the goal is to
isolate the specific effects of an intervention above and
beyond its social contexts. Unfortunately, it is often not
possible to blind patients and providers in studies evalu-
ating the efficacy or relative efficacy of manual therapies.
With this in mind, we took steps in an earlier dose–
response trial on spinal manipulation for cervicogenic
headache to help minimize the effects of expectation
and the doctor-patient encounter (DPE) [13,14]. Chiro-
practors were asked to interact with the study partici-
pants with uniform enthusiasm across study groups. The
chiropractors were monitored by participant question-
naire over time and clinical observation. The question-
naires revealed that the providers could indeed interactwith patients receiving different therapies with equipoise.
Furthermore, expectations over time and the DPE had
little effect on pain outcomes compared to treatment
intervention and baseline pain [14].
These steps were repeated for the current study. We
conducted a much larger randomized trial evaluating the
dose–response and efficacy of spinal manipulative the-
rapy provided by a chiropractor for the care of chronic
LBP [15]. We found that the dose–response gradient
was small and treatment had a modest advantage over
control. The purpose of this report was to confirm the
ability to balance the DPE over treatment groups, and to
present a path analysis modeling the effects of ongoing




The study is presented in detail in the principal report of
outcomes [15]. In a prospective open-label, randomized
controlled trial, 400 participants with chronic LBP were
randomized to receive a dose of 0, 6, 12, or 18 sessions
of SMT from a chiropractor. The protocol called for all
participants to attend 18 visits, three per week for six
weeks. At non-SMT visits, a brief, light massage control
was performed to control provider attention and touch
by the chiropractor. That is, the number of control visits
equaled 18 minus the number of SMT visits. The study
was conducted in the Portland, Oregon metropolitan
area between March 2007 and July 2011.
Computer generated design adaptive allocation [16,17],
implemented immediately before the first treatment, was
used to conceal assignment prior to randomization and ba-
lance important variables at baseline. These included age
and gender, as well as variables relevant to controlling out-
comes and participant expectations: pain and disability
scores, previous care from an SMT or massage provider,
and the relative confidence of the participant in the success
of SMT and massage care for chronic LBP. Data for this
report were collected at baseline and 12-wk primary endpoint
by written questionnaire and by blinded phone interview
two to seven days following the last treatment at 6 weeks.
Protocol
Participants were recruited through craigslist, mailers,
and local newspapers. They were informed during a
scripted interview that the study was investigating 18
visits for different combinations of two manual therapies
for chronic LBP: SMT and light massage. They were told
dispassionately that there was potential benefit from ei-
ther intervention alone or in combination. Eligibility
screening examinations were conducted at a central uni-
versity clinic by one of two chiropractors using history,
physical exam, and lumbar x-rays [18]; they gave the
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sage protocols. Eligible participants selected a conveni-
ent clinic for study care. Care was provided by one of 12
licensed chiropractors with 4 to 24 years of experience
in nine Portland-area clinics. Participants were compen-
sated for each treatment visit, mailed questionnaires,
and phone interviews ($10 to $20). Participants signed
an informed consent form. Protection of human subjects
was approved by the University of Western States
Institutional Review Board.
The treating chiropractors interacted with the patients
at each 15-minute treatment visit. They took brief his-
tories and chatted with the patients as in usual practice.
Of particular pertinence to this report, the chiropractors
were asked to interact with the participants with equal
enthusiasm for care across the different interventions
and doses of care. This was instituted to help create ba-
lance of expectations for treatment success imparted by
the practitioner.
The need for equipoise was discussed during two
training sessions in the preparation phase of the study
and reinforced during quarterly training sessions. A
study investigator (chiropractor) also gave feedback to
the treating chiropractors if he noted any patterns of un-
intentional breach of equipoise across groups during
study visit observations. Equipoise in enthusiasm and
other variables were evaluated through patient question-
naire described below [13-15].Participants
Participants were required to be at least 18 years old, have
a current episode of chronic LBP [19] of mechanical origin
[20] of at least three months duration [21], have had some
LBP on 30 days in the prior six weeks, and had a minimum
LBP index of 25 on a 100-point scale to prevent floor ef-
fects. Participants were excluded if they received manual
therapy within the previous 90 days. They were also ineli-
gible if they had contraindications to study interventions
[18,22] or complicating conditions such as active cancer,
spine pathology, inflammatory arthropathies, autoimmune
disorders, anti-coagulant conditions, neurodegenerative
diseases, pain radiating below the knee, organic referred
pain, pregnancy, and disability compensation.Intervention
Participants spent 15 minutes with a treating chiroprac-
tor. They received a hot pack for five minutes to relax
spinal muscles followed by five minutes for the SMT or
control intervention. The visit was completed with five
minutes of very low dose pulsed ultrasound (20% duty
cycle with 0.5 watts/cm2). This was used as a quasi-
sham to enhance treatment credibility and adherence to
care [23].SMT consisted of thrust spinal manipulation in the
lumbar and transition thoracic regions, predominantly
in the side-posture position [24]. Specific manipulations
to be performed were determined at each visit by the
chiropractor through ongoing evaluation of the partici-
pants [18]. The light massage control consisted of five
minutes of gentle effleurage and petrissage of the low
back (lumbar and lower thoracic) paraspinal muscles
[24,25], focused on the symptomatic areas. The massage
used was gentler and of shorter duration than recom-
mended for therapeutic massage practice [26,27]. It was
a minimalist intervention to control touching the patient
and was not a formal sham.
Study variables in the analysis
Low back pain intensity, a primary study outcome, was
evaluated using the Modified Von Korff pain scale of
Underwood et al. [28]. It is the average of three 11-point
numerical rating scales pain today, worst pain in the
last 4 wk, and average pain in the last four wk. The
scale is scored from 0 to 100 with a lower score being
more favorable. The scale has been shown to be reli-
able, valid, and responsive for measuring pain (inclu-
ding headache) and was chosen for its brevity, simplicity,
acceptability to participants, and validity as a phone
questionnaire [28].
Patient expectation was evaluated as confidence in the
success of assigned study intervention using Interstudy’s
Low Back Pain TyPE Specification instrument [29]. The
6-point Likert scales were anchored by “extremely
doubtful” and “extremely certain”. Expectation of success
for spinal manipulation and light massage were evalu-
ated at baseline prior to randomization. The specific
questions were: “How confident are you that 18 visits for
spinal manipulation plus ultrasound therapy will be able
to successfully treat your back problem?” and “How
confident are you that 18 visits for light massage plus
ultrasound therapy will be able to successfully treat your
back problem?” The average value of the two scales was
included in the analysis. At the 6- and 12-wk follow-ups,
a single question was administered: “How confident are
you that the care you received is working?”
Measures of the DPE included patient perception of
chiropractor enthusiasm for care, comfort treating low
back pain, confidence in care success, and adequate time
spent with the patient. An example question was, “My
doctor seemed enthusiastic about my treatment pro-
gram”. The four variables were measured on 5-point
Likert scales anchored by “strongly disagree” to strongly
agree” [30,31]. A “could not tell” response option was
added for the enthusiasm, comfort, and confidence ques-
tions based on participant feedback in our previous
study [14]. This response was coded as the neutral score
3 on the 5-point scale. The average of the four scales
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analysis.
Statistical analysis
Path analysis fitted using structural equation modeling
software [32,33] was conducted to identify the direct, in-
direct, and total effects of manipulation dose, prior low
back pain intensity the DPE, and patient expectancy of
treatment success on chronic LBP intensity. This was a
preplanned secondary analysis of our study data.
 The direct effect (βdirect) of one variable on another
variable in the model is described by a path
coefficient. The coefficient represents the effect of
an independent variable (v1) on a dependent
variable (v2) controlling for other predictors of v2 in
the model, as in a multiple regression analysis. The
standardized path coefficients correspond to all
variables in the analysis standardized to a mean of
zero and a variance of 1.0. This standardization
yields path coefficients on a common scale (from −1
to 1) and enables comparison of effects of different
variables. Quantitatively, the standardized path
coefficient represents the change in the dependent
variable in standard deviations for a one standard
deviation change in the independent variable
(larger absolute values of the coefficient correspond
to stronger effects). The coefficients are included in
the graphical depiction of the model. The arrows
represent the direction of presumed influence
(v1 → v2).
 The indirect effect (βindirect) is the effect of independent
variable (v1) on dependent variable (v2) that is
mediated by variables on the paths between v1 and v2.
For example, assume that v2 has six predictors (v1 to
v6) and that the indirect effect contains three paths
with mediating variables v3 and v4 (v1→ v3→v2,
v1→ v4→v2, and v1→ v3→ v4→v2). The indirect
effect is quantified by first computing the product of
the path coefficients on each of the three paths and
then summing the products for the three paths. The
indirect effect is controlled for all predictors of v2 not
serving as mediating variables on the paths, in this case
v1, v5, and v6.
 The total effect (βtotal) of one variable on another is
the sum of the direct and indirect effect connecting
the two variables: βtotal = βdirect + βindirect. The total
effect represents the effect of v1 on v2 that is
independent of all variables that are, according to
the model, not caused (directly or indirectly) by v1.
The total effect is important because it expresses the
total estimated effect of v1 on v2. Note that the
total effect can be meaningfully larger or smaller
than the direct effect (path coefficient).Modeling was guided by several principles in deter-
mining potential pathways of influence of one variable
on another or, stated simply, the presence and direction
of pathway arrows between variables in the path analysis
model diagram. 1) Both SMT dose and DPE were con-
sidered to be interventions. 2) Dose was assumed to
affect DPE and expectations. 3) Baseline pain was as-
sumed to affect pain at 6 weeks and at 12 weeks. 4)
Baseline expectations were assumed to affect expecta-
tions at 6 weeks and at 12 weeks. 5) Baseline expecta-
tions were also assumed to affect the DPE at 6 weeks. 6)
All variables evaluated at 6 weeks were presumed to in-
fluence all variables at 12 weeks. 7) DPE was assumed to
affect concurrent pain and expectations and pain was as-
sumed to affect concurrent expectations. 8) It was noted
that feedback loops, such as pain influencing expecta-
tions and expectations influencing pain, could not be
incorporated in the models.
Models were fit by the maximum likelihood method.
Confidence intervals and p-values were calculated by the
bootstrap with 500 resamples of patients with replace-
ment. The fitted model was considered satisfactory be-
cause all of the following conditions were met (model fit
in parentheses): a) a statistically non-significant likeli-
hood ratio test of the fitted model vs. the saturated
model, indicating no important paths were omitted
(model: p = .11); b) a statistically significant likelihood
ratio test of the model vs. the baseline model, indicating
improvement against a model that assumes no non-null
associations (model: p < 0.001); c) the root mean squared
error of approximation RMSEA <0.05, indicating small
residual variation (model: 0.043); and d) the comparative
fit index CFI > 0.95 (model: 0.996) and the Tucker-Lewis
index TLI > 0.95 (model: 0.997), supporting a favorable
comparison of our model to the saturated and baseline
models. The multivariate normality assumption was
confirmed by normal quantile-quantile plots of resi-
duals. Strong multicollinearity was ruled out using the
variance-inflation factor.
Treatment was included as a dose variable represen-
ting the linear effect of the number of visits for spinal
manipulation (0, 6, 12, or 18.) In a second analysis, three
grouping variables were introduced to evaluate the ef-
fects of the three manipulation dose groups compared to
the control on the model outcomes.
Each participant was included in the original allocation
group (intention-to-treat analysis). Missing data were
imputed using linear interpolation, when bracketing data
were available, and last datum carried forward when last
data points were unavailable [15]. Nine participants were
omitted from the analysis because they had no follow-up
data, so that 391 were included in the analysis. The sam-
ple size was set in advance to have 80% power to detect
a 10-point difference between two treatment groups on
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level of significance [15]. For the path analysis, statis-
tical significance was set at the .05 level. All analyses
were conducted with Stata 11.2 (Stata Corp, College
Station, TX).
Results
Figure 1 shows adherence to care and compliance with
follow-up. Further details are published elsewhere [15].
There was strong adherence to care with 90% to 95% of
participants in each group attending all 18 study visits.
Compliance with follow-up data collection was also very
good: 95% to 99% at six weeks and 85% to 92% at 12 wk.
During the treatment phase, 93% to 97% of participants
in each treatment arm refrained from professional care
outside of the study.
The mean participant age was 41.3 years and 85% were
white non-Hispanic. Approximately half reported each
of the following characteristics: female, college degree,
comorbidity, and experience with a study intervention.
The mean duration of low back pain was 11.8 years and
the mean frequency was 6 days per wk. Baseline charac-
teristics were well balanced across groups [15].
Outcomes
Variables included in the path analysis are shown in
Table 1. Mean pain improvement for each group at both
follow-ups is considered clinically important for an indi-
vidual patient [34-36]. Mean improvement at the end of
care was durable to 12 weeks.Phone Screen (n = 3
Baseline Exam 1 (n 
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Figure 1 Study flowchart.Confidence in SMT and light massage was successfully
balanced across treatment groups at baseline by the allo-
cation program. Overall baseline mean scores demon-
strated little certitude for success of care for either SMT
or light massage (3.7 and 3.5, respectively).
Pairwise comparisons to the control group showed
that expectations were greater in the two highest dose
groups at both follow-up time points (t-tests, p < .05).
This is commensurate with the greater improvement in
pain seen in the highest dose groups (Table 1) [15].
We were successful in achieving uniform patient per-
ceptions of the doctor-patient encounter across treat-
ment groups at both 6 and 12 weeks. Group means for
the composite score differed by 0.1 or less on the 5-
point scale (p > .05).
Pairwise correlations
Pairwise correlations between variables in the model are
presented in Table 2. The strongest correlations were be-
tween like variables at the different time points, such as
pain at six and 12 weeks (r = 0.72). There was also sub-
stantial correlation between follow-up pain and expecta-
tions. The association of DPE with pain and expectation
were not as large. Notably, dose was not strongly corre-
lated with any variable.
Path analysis model
The path analysis schematic with the estimated direct ef-
fects is presented in Figure 2. Thicker arrows show lar-
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Table 1 Variables in the path analysis models*
Week n 0 SMT n 6 SMT n 12 SMT n 18 SMT n All
Low back pain
Pain intensity (0 – 100: mean of pain today, worst pain in last 4 weeks, and average pain over last four weeks)
0 95 52.2 (16.3) 99 51.0 (18.2) 97 51.6 (17.5) 100 51.5 (16.8) 391 51.6 (17.2)
6 95 34.5 (18.4) 99 32.3 (15.8) 97 27.1 (14.7) 100 30.2 (19.0) 391 31.0 (17.2)
12 95 37.9 (20.4) 99 32.7 (19.4) 97 29.0 (20.8) 100 31.4 (19.8) 391 32.7 (20.3)
Expectations (6-point Likert scale: 0 extremely doubtful, 3 unsure, and 6 extremely certain)
Confidence at baseline
0 in SMT 95 3.6 (1.2) 99 3.8 (1.1) 97 3.7 (1.2) 100 3.8 (1.1) 391 3.7 (1.2)
0 in LM 95 3.4 (1.2) 99 3.5 (1.2) 97 3.4 (1.2) 100 3.5 (1.2) 391 3.5 (1.2)
0 average 95 3.5 (1.1) 99 3.7 (1.1) 97 3.5 (1.1) 100 3.7 (1.1) 391 3.6 (1.1)
Confidence that care received is working
6 95 3.2 (1.8) 97 3.9 (1.7) 96 4.4 (1.3) 99 4.2 (1.6) 387 3.9 (1.7)
12 86 3.1 (1.8) 90 3.2 (1.7) 88 3.9 (1.4) 92 3.7 (1.6) 356 3.5 (1.7)
Doctor-patient encounter (5-pt Likert scale: 1 strongly disagree to 5 strongly agree)
My doctor seemed comfortable dealing with my back pain
6 95 4.8 (0.5) 97 4.8 (0.7) 96 4.8 (0.5) 99 4.8 (0.4) 387 4.8 (0.5)
12 86 4.5 (0.8) 90 4.6 (0.7) 89 4.5 (0.9) 92 4.5 (0.8) 357 4.5 (0.8)
My doctor seemed enthusiastic about my treatment program
6 95 4.4 (0.9) 97 4.4 (0.8) 96 4.6 (0.8) 99 4.5 (0.7) 387 4.5 (0.8)
12 86 4.0 (1.0) 90 4.2 (0.9) 89 4.1 (1.0) 92 4.1 (1.0) 357 4.1 (1.0)
My doctor spend adequate time listening to my description of the pain
6 95 4.6 (0.8) 97 4.7 (0.7) 96 4.7 (0.7) 99 4.7 (0.6) 387 4.7 (0.7)
12 85 4.6 (0.8) 89 4.4 (0.9) 89 4.5 (1.0) 92 4.5 (0.8) 355 4.5 (0.9)
My doctor seemed confident that the treatment provided would work
6 95 3.4 (0.9) 97 3.6 (0.9) 96 3.7 (0.9) 99 3.7 (0.9) 387 3.6 (0.9)
12 86 3.3 (0.9) 90 3.6 (1.0) 89 3.6 (1.0) 92 3.5 (1.0) 357 3.5 (1.0)
Average patient impression of DC comfort, enthusiasm, confidence in tx success, and adequate time listening
6 95 4.3 (0.5) 97 4.4 (0.5) 96 4.4 (0.5) 99 4.4 (0.4) 387 4.4 (0.5)
12 85 4.1 (0.7) 89 4.2 (0.7) 89 4.2 (0.8) 92 4.1 (0.7) 355 4.2 (0.7)
*The Mean (SD) is presented for each variable in the model for each spinal manipulation dose level (0, 6, 12, and 18 manipulation visits) and the total sample.
Data are presented for model variables at baseline (0 weeks), end of care (6 weeks), and subsequent follow-up (12 weeks). Note that the variables in the model
for baseline expectations and the doctor-patient encounter are computed averages of preceding variables in the table.
SMT spinal manipulative therapy (spinal manipulation).
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are included in Table 3 for all variables in the model;
boldface results are statistically significant at the p < 0.05
level. Unless otherwise noted, the results reported in the
remainder of the text are statistically significant and in-
clude only the total effects abbreviated as β.
Main findings: The principal finding was that the DPE
evaluated at the end of care and SMT dose had similar ef-
fects on pain outcomes. DPE β = −0.22 and −0.15 and dose
β = −0.11 and −0.12 for the six and 12-wk pain outcomes,
respectively. The unstandardized dose effect on 12-wk pain
(using the original 100-point pain scale) was −2.2 points
per 6 visits. The negative signs indicate that a more favor-
able view of the DPE and a larger dose of SMT wereassociated with less pain at follow-up. The other major
finding was that baseline expectations had little total effect
on pain for both follow-up time points (β’s = −0.05, p > .05).
Low back pain: LBP intensity at a given time point was
the strongest determinant of future LBP intensity. For
example, 6-wk and baseline pain were the greatest deter-
minants of 12-wk pain (β = 0.66 and 0.41, respectively).
Six-wk LBP had notable effects on follow-up expecta-
tions (β = −0.54 and −0.45). The negative signs show that
greater pain was associated with poorer confidence that
treatment was working after completion of care and later
follow-up. Conversely, at baseline greater pain was asso-
ciated with greater confidence in the success of any
study care (β = 0.27).











Baseline Baseline 6 weeks 6 weeks 6 weeks 12 weeks 12 weeks 12 weeks
Low back pain – baseline 0.27 −0.01 0.44 0.00 0.01 0.41 0.00 0.00
Expectations – baseline - 0.04 0.07 0.20 0.14 0.07 0.15 0.13
Dose - - −0.12 0.23 0.06 −0.13 0.17 −0.01
Low back pain – 6 weeks - - - −0.50 −0.23 0.72 −0.44 −0.19
Expectations – 6 weeks - - - - 0.35 −0.42 0.73 0.33
Dr-Patient encounter – 6 weeks - - - - - −0.16 0.30 0.59
Low back pain – 12 weeks - - - - - - −0.47 −0.17
Expectations – 12 weeks - - - - - - - 0.34
Dr-Patient encounter – 12 weeks
*Pearson’s correlation coefficient shows the univariate correlation between variables.
Bolded coefficients are statistically significant (p < .05).
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effect on pain at the end of care and at the primary
follow-up time point. A greater number of SMT sessions
also produced greater confidence that the treatment is
working. However, dose had no notable influence on the
DPE for both follow-up time points (|β| ≤ 0.05, p > .05).
Doctor-patient encounter: The DPE evaluated at
the end of care was a strong determinant of the
DPE score at 12 weeks (β = 0.59). and, as mentioned
above, was a determinant of low back pain at both





















Figure 2 Path analysis diagram. Standardized path coefficients are prese
relationship between variables and the arrow points to the presumed direc
and the width of solid arrows indicates the magnitude of the coefficient. C
blue = expectations, black = treatment dose.the end of care was associated with greater confi-
dence that treatment was working at both follow-ups
(β = 0.32 and 0.26). As mentioned above, the DPE
was a determinant of low back pain at both follow-
ups. When a sensitivity analysis was conducted with
reverse pain-DPE paths in the model, the path coef-
ficients were trivial indicating that pain was a poor
determinant of DPE.
Expectations: Expectations affected future expecta-
tions. Notably, confidence that care is working at 6


























nted. The absolute magnitude indicates the strength of the
tion of influence. Solid arrows indicate statistical significance (p < .05)
olor of the arrow indicates variable of origin; green = pain, red = DPE,
Table 3 Path analysis*
Dependent variables Direct effects Indirect effects Total effects
Determinants β 95% CI β 95% CI β 95% CI
Expectations – baseline (R2 = 0.07)
Low back pain – baseline 0.27 (0.17, 0.37) 0.27 (0.17, 0.37)
Doctor-Patient encounter – 6 weeks (R2 = 0.02)
Expectations – baseline 0.15 (0.04, 0.26) 0.15 (0.04, 0.26)
Low back pain- baseline −0.03 (−0.14, 0.08) 0.04 (0.01, 0.07) 0.01 (−0.09, 0.11)
Dose 0.05 (−0.05, 0.16) 0.05 (−0.05, 0.16)
Low back pain – 6 weeks (R2 = 0.26)
Expectations – baseline −0.01 (−0.11, 0.08) −0.03 (−0.06, -0.01) −0.05 (−0.14, 0.05)
Doctor-Patient encounter – 6 weeks −0.22 (−0.31, -0.13) −0.22 (−0.31, -0.13)
Low back pain- baseline 0.45 (0.36, 0.54) −0.01 (−0.04, 0.03) 0.44 (0.35, 0.54)
Dose −0.10 (−0.19, -0.01) −0.01 (−0.04, 0.01) −0.11 (−0.21, −0.02)
Expectations – 6 weeks (R2 = 0.40)
Expectations – baseline 0.15 (0.06, 0.25) 0.05 (−0.01, 0.12) 0.21 (0.09, 0.32)
Doctor-Patient encounter – 6 weeks 0.20 (0.11, 0.30) 0.12 (0.07, −0.17) 0.32 (0.21, 0.43)
Low back pain – 6 weeks −0.54 (−0.63, −0.45) −0.54 (−0.63, −0.45)
Low back pain – baseline 0.20 (0.11, 0.30) −0.20 (−0.28, −0.11) 0.01 (−0.09, 0.11)
Dose 0.15 (0.07, 0.23) 0.07 (0.01, 0.13) 0.22 (0.13, 0.32)
Doctor-Patient encounter – 12 weeks (R2 = 0.37)
Expectations – baseline 0.11 (0.04, 0.18) 0.11 (0.04, 0.18)
Doctor-Patient encounter – 6 weeks 0.55 (0.45, 0.65) 0.05 (0.04, 0.18) 0.59 (0.49, 0.69)
Low back pain – 6 weeks −0.01 (−0.13, 0.10) −0.07 (−0.08, −0.06) −0.09 (−0.20, 0.03)
Expectations – 6 weeks 0.13 (0.01, 0.25) 0.13 (0.01, 0.25)
Low back pain- baseline 0.00 (−0.08, 0.08) 0.00 (−0.08, 0.08)
Dose −0.07 (−0.15, 0.02) 0.06 (0.00, 0.13) −0.01 (−0.11, 0.09)
Low back pain – 12 weeks (R2 = 0.54)
Expectations – baseline −0.05 (−0.12, 0.02) −0.05 (−0.12, 0.02
Doctor-Patient Encounter – 6 weeks 0.06 (−0.03, 0.14) −0.20 (−0.26, −0.14) −0.15 (−0.25, -0.04)
Low back pain – 6 weeks 0.59 (0.49, 0.69) 0.07 (0.06, 0.08) 0.66 (0.55, 0.76)
Expectations – 6 weeks −0.12 (−0.21, -0.03) −0.01 (−0.02, −0.00) −0.13 (−0.22, −0.04)
Doctor-Patient encounter – 12 weeks −0.06 (−0.15, 0.03) −0.06 (−0.15, 0.03)
Low back pain- baseline 0.15 (0.06, 0.24) 0.26 (0.19, 0.33) 0.41 (0.31, 0.51)
Dose −0.03 (−0.10, 0.03 −0.09 (−0.15,−0.02) −0.12 (−0.21, -0.03)
Expectations – 12 weeks (R2 = 0.58)
Expectations – baseline 0.03 (−0.05, 0.10) 0.15 (0.07, 0.23) 0.18 (0.05, 0.30)
Doctor-Patient encounter – 6 weeks −0.04 (−0.13, 0.06) 0.30 (0.22, 0.38) 0.26 (0.13, 0.40)
Low back pain – 6 weeks 0.04 (−0.08, 0.16) −0.49 (−0.56, -0.43) −0.45 (−0.58, −0.32)
Expectations – 6 weeks 0.63 (0.53, 0.73) 0.04 (0.02, 0.07) 0.68 (0.57, 0.78)
Doctor-Patient encounter – 12 weeks 0.13 (0.05, 0.21) 0.01 (−0.01, 0.03) 0.14 (0.06, 0.23)
Low back pain – 12 weeks −0.22 (−0.32, −0.12) −0.22 (−0.32, −0.12)
Low back pain- baseline −0.06 (−0.14, 0.03) −0.06 (−0.14, 0.03)
Dose 0.16 (0.08, 0.23) 0.16 (0.08, 0.23)
*Standardized coefficients (β) and 95% confidence intervals (95% CI) are presented for direct effects (path coefficients connecting two variables in Figure 2), indirect effects
(computed from all multi-arrow paths connecting two variables), and total effects (sum of direct and indirect effects). Bolded coefficients are statistically significant (p < .05).
R2 shows the proportion of the total variation of each dependent variable that is explained by the model. R2 = 0.36 for the entire model.
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more positive future DPE and better pain outcomes at
the 12-wk follow-up.
Effects of SMT dose groups
When the linear dose variable was replaced in the sec-
ondary analysis with three indicator variables comparing
each treatment group to the control, all non-dose path
coefficients and effects were left essentially unchanged.
The results for dose paralleled those presented above
with the largest effects found for the highest two dose
groups, particularly for 12 sessions of SMT. There were
only two notable effects of dose on pain intensity,
namely for 12 SMT sessions of SMT at both follow-ups
(β = −0.18). This corresponds to an advantage for 12
SMT sessions over the control of −7.1 and −8.5 points
on the 100-point scale, respectively.
Discussion
Doctor-patient encounter
Our study underscores the importance of controlling the
encounter between patient and provider in unblinded ef-
ficacy studies. The DPE can make a relatively important
impact on outcomes, and differential behavior on the
part of study treatment providers may have a confound-
ing effect. We recommend that investigators report on
method and degree of success in controlling the DPE.
This study confirms that chiropractors practicing in
private clinics can maintain equipoise in providing study
care in a randomized controlled trial with minimal train-
ing and oversight. The treating chiropractors were
instructed to “be themselves” in their interaction with
the participants and demonstrate equal enthusiasm
across all study groups. Table 1 shows that in addition to
success in achieving uniformity in participant percep-
tion of clinician enthusiasm, the study achieved balance
in perception of clinician comfort with and confidence
in care. Equipoise was demonstrated for type of inter-
vention (spinal manipulation or brief light massage)
and dose (number of visits for interventions) in this
study of LBP and our previous study of cervicogenic
headache [14].
It is well known that the DPE can have notable health
benefits [23]. This study showed the relative effect of the
DPE on efficacy under the conditions of a randomized
trial, where treatment and what clinicians can say to the
participants are restricted by study protocol. Practi-
tioners should consider ways to benefit the patient by
enhancing this effect in general practice.
Expectations
Baseline expectations in this study influenced pain out-
comes neither directly nor indirectly through its effects
on later DPE and confidence in care. The mixed resultsfound in the literature [5-9] for the association of base-
line expectations with outcomes in LBP studies may be
attributable to differences in expectation instrument,
outcome measures [6], treatment and control interven-
tions, magnitude of treatment effect, patient population,
study design (placebo-controlled or comparative study),
timing relative to informed consent and randomization,
modeling techniques (e.g., regression or causal mode-
ling), or variables included in the model.
Controlling baseline expectations in the conduct and
analysis of randomized trials can also be challenging.
Baseline expectations for each intervention can be bal-
anced across groups through randomization. However,
expectations in the participant population can be differ-
ent for each study intervention, and hence, the mean ex-
pectation for participants’ assigned treatment can be
different across treatment arms [14]. The analysis could
include adjustment for patient expectation for any or all
of the treatments or just the expectation for the assigned
treatment. The choice of expectation covariates can yield
different adjusted treatment effects. Disclosure rules
about placebo and sham interventions can also affect
baseline expectations, an additional reason to include
expectations in the analysis of treatment effects.
Expectations of treatment success reported at the end
of care and at later follow-up were not equal across
groups; the higher dose groups had greater confidence
treatment was working (Table 1). This may be attributed
to the fact that pain had a strong effect on expectations
and higher SMT dose groups had better pain outcomes.
Coupled with this, higher dose was also associated with
greater expectations. This illustrates how expectations
after baseline might more appropriately be considered
an outcome rather than a nuisance variable that can be
adjusted for in the analysis.
Model effects
This study demonstrates the importance of examining
indirect and total effects in addition to the direct ef-
fects or path coefficients in Figure 2 and Table 3.
Indirect effects can significantly enhance or cancel di-
rect effects, so exclusion of them can be misleading.
For example, the path coefficient for the effect of dose
on 12-wk LBP (βdirect = −0.03) could lead to the con-
clusion that the quantity of SMT visits had no causal
relationship with LBP at this time point. However,
inclusion of the indirect effect of dose on 12-wk
pain, mediated predominantly through 6-wk pain
(βindirect = −0.09), yielded a statistically significant total
effect at 12 weeks (β = −0.12). This is comparable
to the causal relationship with pain at 6 weeks (β = −0.11).
A canceling influence of an indirect effect is illustrated
by the relationship of baseline LBP to 6-wk expectations.
The direct effect was βdirect = 0.20, although the near
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(β = 0.01).
A comparison with our previous path analysis model
for cervicogenic headache is difficult because sample size
of that preliminary model limited the number of paths
that could be included and the precision of path coeffi-
cient estimates [14]. A major similarity between the two
studies was the finding of an effect of pain on expecta-
tions. The most important difference between the two
was that relative to the effects of DPE and expectations,
there was a much larger effect of treatment on pain in
the headache study.Limitations
There are two principal limitations of the study. The
first is the limited number of variables used to quantify
the DPE. Our purpose was to observe the differential ef-
fects of patient perception of the doctor on patient out-
comes in an open-label randomized trial. More extensive
evaluation with a fully validated instrument might paint
a different picture of DPE impact. The second major
limitation is the structure of the model itself. Both the
variables included and the paths of influence selected
can affect path coefficients [32,33]. In our case, we are
encouraged by the fact that the differences between
SMT dose groups and control group presented in the
secondary analysis above are virtually identical to the
findings of the primary analysis for this randomized trial
[15]. A final caution must be paid to the generalizability
of DPE findings from a randomized trial to the clinical
setting. The DPE here was carefully circumscribed by
the protocol, particularly when it came to giving patients
advice. In clinical practice the patient-provider inter-
action is potentially much broader and much richer in
character.Conclusions
The doctor-patient encounter can have a relatively im-
portant effect on outcomes in open-label randomized
trials of treatment efficacy, both directly and mediated
indirectly through participant expectations. Therefore,
attempts should be made to engender equivalence of the
patient perception of the encounter across treatment
groups and then report on the success of that effort.
Even with limited training of the treating chiropractors
in this randomized trial, we were successful in achieving
uniformity in overall patient perception of the doctor’s
enthusiasm, comfort with treatment, and confidence
across groups.
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